Recent Finacing
Recent Raise
Patara Pharma is a clinical-stage biotech developing PA101B, a GPR35 agonist in Phase II trials for refractory chronic cough and indolent systemic mastocytosis, focused on allergic and inflammatory orphan populations.
Focus Areas
Total Raised
Funding round